Please login to the form below

Not currently logged in
Email:
Password:

New finance head for Xenon

Ian Mortimer joins from Tekmira

Xenon Pharmaceuticals has appointed Ian Mortimer as chief financial officer.

Mortimer will join Xenon on November 1, 2013. He has more than 15 years' experience in the biotechnology sector.

Currently with Tekmira Pharmaceuticals Corporation, as executive VP and chief financial officer, Mortimer is responsible for all aspects of the company's finance and capital markets activities and led Tekmira's listing on Nasdaq in 2010.

Prior to joining Tekmira, Mortimer was chief financial officer at Inex Pharmaceuticals Corporation. He has an MBA from Queen's University, a BSc in microbiology from the University of British Columbia and is a Certified Management Accountant.

"We are delighted to welcome Ian to the team. He brings a combination of strong financial and operations experience that is highly relevant to Xenon," said Dr Simon Pimstone, Xenon's president and CEO.

"Given our pipeline of approved, development stage and discovery stage products and programmes, together with our strong balance sheet and our suite of major pharmaceutical partnerships, this is a good time for Xenon to be adding an experienced CFO like Ian to the company," Pimstone added.

13th September 2013

From: Sales

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....

Infographics